Multiparametric MRI Radiomics and Machine Learning Framework for Predicting Treatment Response in Glioblastoma
Distinguishing True Progression (TP) from Pseudo-Progression (PsP) after chemoradiotherapy remains a major diagnostic challenge in GBM, as both entities present near-identical appearances on conventional contrast-enhanced post-treatment MRI. This distinction carries substantial clinical weight, since TP and PsP demand...